Aspiriant LLC’s iShares Russell Mid-Cap Value ETF IWS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$203K Sell
1,265
-205
-14% -$34.4K 0.01% 407
2026
Q2
$242K Sell
1,470
-121
-8% -$19.1K 0.01% 350
2026
Q1
$232K Sell
1,591
-1,662
-51% -$247K 0.01% 315
2025
Q4
$459K Buy
3,253
+809
+33% +$113K 0.01% 224
2025
Q3
$341K Sell
2,444
-2,506
-51% -$343K 0.01% 236
2025
Q2
$654K Buy
4,950
+2,492
+101% +$313K 0.02% 178
2025
Q1
$310K Hold
2,458
– – 0.01% 232
2024
Q4
$318K Buy
2,458
+729
+42% +$97.6K 0.01% 231
2024
Q3
$229K Hold
1,729
– – 0.01% 263
2024
Q2
$209K Hold
1,729
– – 0.01% 269
2024
Q1
$217K Hold
1,729
– – 0.01% 301
2023
Q4
$201K Buy
+1,729
New +$184K 0.01% 301

Other funds holding IWS

Aspiriant LLC's IWS Position: Q3 2026 in Review

Aspiriant LLC reduced its iShares Russell Mid-Cap Value ETF (IWS) stake by 14% in Q3 2026, selling an estimated $34.4K and leaving 1,265 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #407.

Aspiriant LLC first reported a position in IWS in Q4 2023 and has held it in 12 quarters since. The position peaked at $654K in Q2 2025. 287 funds tracked by Wall St. Rank hold IWS as of Q3 2026.

  • Aspiriant LLC held 1,265 shares of iShares Russell Mid-Cap Value ETF worth $203K as of Q3 2026.
  • Aspiriant LLC sold 205 iShares Russell Mid-Cap Value ETF shares in Q3 2026, an estimated $34.4K.
  • iShares Russell Mid-Cap Value ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #407 holding.
  • Aspiriant LLC first reported a position in iShares Russell Mid-Cap Value ETF in Q4 2023 and has held it in 12 quarters since.
  • Aspiriant LLC's iShares Russell Mid-Cap Value ETF position peaked at $654K in Q2 2025.
  • 287 funds tracked by Wall St. Rank held iShares Russell Mid-Cap Value ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.